The store will not work correctly when cookies are disabled.
(E)-3-(2-hydroxyphenyl)-1-(5-isopropylpyrazin-2-yl)prop-2-en-1-one
ID: ALA2288841
PubChem CID: 76313030
Max Phase: Preclinical
Molecular Formula: C16H16N2O2
Molecular Weight: 268.32
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)c1cnc(C(=O)/C=C/c2ccccc2O)cn1
Standard InChI: InChI=1S/C16H16N2O2/c1-11(2)13-9-18-14(10-17-13)16(20)8-7-12-5-3-4-6-15(12)19/h3-11,19H,1-2H3/b8-7+
Standard InChI Key: ITYFEJCSHIFTBZ-BQYQJAHWSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
10.0731 -6.4632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0720 -7.2827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7800 -7.6917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4897 -7.2823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4869 -6.4596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7783 -6.0543 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1930 -6.0483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9023 -6.4543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1900 -5.2312 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6085 -6.0430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3177 -6.4489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3177 -7.2650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0261 -7.6708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7332 -7.2595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7275 -6.4381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0185 -6.0360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3640 -7.6908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6566 -7.2816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3633 -8.5080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0118 -5.2188 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
2 17 1 0
17 18 1 0
17 19 1 0
16 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 268.32 | Molecular Weight (Monoisotopic): 268.1212 | AlogP: 3.20 | #Rotatable Bonds: 4 |
Polar Surface Area: 63.08 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.85 | CX Basic pKa: ┄ | CX LogP: 2.91 | CX LogD: 2.90 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.68 | Np Likeness Score: -0.06 |
References
1. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |